ANIMATION

VIBATIV® Mechanism of Action

GlaxoSmithKline (gsk) commissioned XVIVO to create a mechanism of action animation for VIBATIV® (televancin), used in the treatment of hospital-acquired MRSA. VIBATIV® works by inhibiting cell wall synthesis, severely restricting cellular replication.

Project


VIBATIV® Mechanism of Action


Client


GlaxoSmithKline

XVIVOs attention to detail and ability to create an engaging, easy to understand story behind this extraordinary product was key to bringing natures generous contribution to life .

Senior Researcher, FrieslandCampina